Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Assets Average (2016 - 2025)

Historic Assets Average for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $14.8 million.

  • China Pharma Holdings' Assets Average rose 665.24% to $14.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year increase of 665.24%. This contributed to the annual value of $15.7 million for FY2024, which is 845.65% down from last year.
  • Latest data reveals that China Pharma Holdings reported Assets Average of $14.8 million as of Q3 2025, which was up 665.24% from $14.0 million recorded in Q2 2025.
  • China Pharma Holdings' 5-year Assets Average high stood at $21.8 million for Q1 2022, and its period low was $13.9 million during Q3 2024.
  • In the last 5 years, China Pharma Holdings' Assets Average had a median value of $16.5 million in 2023 and averaged $17.0 million.
  • Per our database at Business Quant, China Pharma Holdings' Assets Average soared by 665.78% in 2022 and then tumbled by 1957.43% in 2023.
  • Over the past 5 years, China Pharma Holdings' Assets Average (Quarter) stood at $20.4 million in 2021, then fell by 16.76% to $17.0 million in 2022, then decreased by 6.37% to $15.9 million in 2023, then dropped by 10.9% to $14.2 million in 2024, then rose by 4.3% to $14.8 million in 2025.
  • Its last three reported values are $14.8 million in Q3 2025, $14.0 million for Q2 2025, and $14.6 million during Q1 2025.